Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Assets Average (2019 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Assets Average for 7 consecutive years, with $276.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 22.56% year-over-year to $276.7 million, compared with a TTM value of $276.7 million through Dec 2025, down 22.56%, and an annual FY2025 reading of $307.6 million, down 20.46% over the prior year.
  • Assets Average was $276.7 million for Q4 2025 at Arcturus Therapeutics Holdings, down from $295.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $479.0 million in Q1 2021 and bottomed at $276.7 million in Q4 2025.
  • Average Assets Average over 5 years is $389.4 million, with a median of $391.7 million recorded in 2024.
  • The sharpest move saw Assets Average skyrocketed 521.03% in 2021, then decreased 28.61% in 2022.
  • Year by year, Assets Average stood at $413.7 million in 2021, then fell by 10.07% to $372.0 million in 2022, then rose by 19.23% to $443.5 million in 2023, then fell by 19.43% to $357.4 million in 2024, then fell by 22.56% to $276.7 million in 2025.
  • Business Quant data shows Assets Average for ARCT at $276.7 million in Q4 2025, $295.8 million in Q3 2025, and $320.5 million in Q2 2025.